ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor) approved in the EU for people with CF 6 years and older with at least one non-class I mutation in the CFTR ...

A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

Cornell researchers have found a new and potentially more accurate way to see what proteins are doing inside living cells - using the cells' own components as built-in sensors.

Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...